Guideline‐Directed Medical Therapy in Durable Left Ventricular Assist Devices: Why It Is Still Necessary
Journal of the American Heart Association · 18.08.2026 · 15 (16)
DOI: 10.1161/jaha.126.052912 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of the American Heart Association, erschienen am 18.08.2026. Verfasst von Newton Nyirenda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Georgetown University Washington DC USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
. Using a large multi-institutional electronic health record network, the investigators evaluated the association between sacubitril/valsar-tan therapy and clinical outcomes among patients receiving durable LVAD support. After propensity score matching, 923 patients treated with sacubitril/valsar-tan were compared with an equal number of patients who did not receive the drug. During 1 year of fol- low-up, treatment was associated with lower risks of major adverse cardiovascular events, all-cause death,
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Georgetown University Washington DC USA.
- University of Virginia Health System Charlottesville VA USA.
- AdventHealth Orlando FL USA.
ORCID-Profile: Sula Mazimba
Zitieren
APA
Nyirenda, N., & Mazimba, S. (2026). Guideline‐Directed Medical Therapy in Durable Left Ventricular Assist Devices: Why It Is Still Necessary. Journal of the American Heart Association, 15(16). https://doi.org/10.1161/jaha.126.052912
Vancouver
Nyirenda N, Mazimba S. Guideline‐Directed Medical Therapy in Durable Left Ventricular Assist Devices: Why It Is Still Necessary. Journal of the American Heart Association. 2026;15(16). doi:10.1161/jaha.126.052912
BibTeX
@article{Nyirenda2026,
author = {Nyirenda, Newton and Mazimba, Sula},
title = {Guideline‐Directed Medical Therapy in Durable Left Ventricular Assist Devices: Why It Is Still Necessary},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {16},
doi = {10.1161/jaha.126.052912}
}
EUVIMED